Since organic chemistry deals directly with the nature and structure of medications, as well as the nature and structure of our bodies, it is one of the major sciences in general chemistry studies and one of the most significant chemical sciences in pharmaceutical and medical studies. Organic chemistry is simply defined as the study of any compound that contains a carbon atom inside of it. There are approximately 5 million compounds in nature, of which 4.5 million are organic. In addition, a large number of other carbon-containing compounds can now be produced artificially in laboratories. It is important to note that we can also produce organic compounds (containing carbon) from inorganic compounds, as in the synthesis of organic compounds. In the synthesis of urea, as shown in the image below, urea is generated from ammonium cyanate (inorganic) by the application of heat. This illustrates how we may produce organic molecules (containing carbon) from inorganic compounds as well. Pharmaceutical organic chemistry includes analytical methods, pharmacology, metabolism, quality control, and drug chemistry in addition to illness treatments and cures. Many students studying pharmaceutical chemistry will eventually work in a lab. Pharmaceutical chemistry prepares students for professions in biotechnology, pharmaceutical firms, research institutions, and other fields.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia